Xilio Therapeutics, Inc. announced a private placement of 1,953,125 common shares at a price of $0.64 per share for the gross proceeds of $1,250,000 and prefunded warrants at a price of $0.6399 per prefunded warrant for the total gross proceeds of $11,300,000 on March 28, 2024. The private placement is expected to close on April 2, 2024, subject to the satisfaction of customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.09 USD | +7.92% | -5.22% | +98.18% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
65.42 USD | +0.23% | -2.01% | 81.58B | ||
1.09 USD | +7.92% | -5.22% | 37.57M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+98.18% | 37.57M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- Xilio Therapeutics, Inc. announced that it expects to receive $11.3 million in funding